Global Health Progress Highlights Growth of Brazil's Biotechnology Sector

50 %
50 %
Information about Global Health Progress Highlights Growth of Brazil's Biotechnology Sector

Published on March 14, 2014

Author: nondescriptwrin88

Source: slideshare.net

Description

Global Health Progress (GHP) released a fresh report that reveals how a biopharmaceutical sector in...

Global Health Progress Highlights Growth of Brazil's Biotechnology Sector Global Health Progress (GHP) released a fresh report that reveals how a biopharmaceutical sector in Brazil, the tenth largest biopharmaceutical market on earth and the largest in Latin America, is a vital driver due to the economy. For instance, Brazil's biopharmaceutical sector develops high- quality, highly trained jobs, the industry key factor in making a stable economy. Currently, approximately 821 biotechnology companies in Brazil employ almost 100,000 individuals with the average annual salary of approximately US $4,457. Among those companies, six biopharmaceutical companies were featured inside a 2003 report on the top 100 companies to dedicate yourself in Brazil. Not only does the biopharmaceutical sector produce valuable job opportunities for highly skilled workers, this emerging market plays a vital role in fostering public- private partnerships, which leads to more economic growth and greater access to healthcare due to the citizens. Partnerships include the funding of a National Policy for Biotechnology, launched in 2007 to encourage biotechnology applications in five health-related fields. The program aims to generate Brazil a global leader inside sector in ten to fifteen years. Additionally, based on a 2009 study, 51 out of 60 innovative companies in Brazil's biopharmaceutical sector were engaged in collaborative activities with universities and research institutes in Brazil, a boost of 65% in comparison with 2003. Investment in research and development (R&D) and promoting innovation are key ways the Brazilian government helps drive future expansion of the country's biopharmaceutical sector. For instance, R&D investments in Brazil have increased one.5% of GDP this season high tend to be more than 205 professional physicians per 100,000 from the population in the role of investigators for clinical studies. Innovative medicines comprise approximately 42% with the biopharmaceutical market in Brazil, while non-prescription and generic medicines represent 43% and 15% of the Brazilian market, respectively. "In Brazil, promoting innovation is a public policy priority," stated Rafael Oliva, Advisor on the Presidency in the Brazilian Development Bank. "The participation with the Brazilian government in research and development (R&D) is considerable, and the goal would be to both increase innovative

activities in Brazil on the systematic basis, and to consolidate the country's culture of innovation." GHP fact sheet shows how Brazil's investment in research and development (R&D) can provide positive effects throughout the economy, including improving access to healthcare for the citizens from the output of new medicines. For example, Brazilian companies produced around 5,910 medicines and possess 56 medicines currently in development. The growing field of numerous studies is also a significant element in improving usage of healthcare. Brazil's large population of 190 million people, with 8 out of every 10 residents moving into or near a town, means medical trial recruitment and participation is rather robust. Brazil's robust investment in promoting innovation is contributing on the global expansion of the biopharmaceutical sector, which produces a positive relation to the overarching global health goals of fostering global competitiveness, lowering the health insurance and economic burden of disease on local citizens, developing tomorrow's medicines and expanding usage of healthcare.

Add a comment

Related presentations

Related pages

Medicine :: Global Health Progress Highlights Growth of ...

Global Health Progress ... Medicine :: Global Health Progress Highlights Growth of Brazil?s Biotechnology Sector ...
Read more

Medicine :: Global Health Progress Highlights Growth of ...

Medicine :: Global Health Progress Highlights Growth of Brazil?s Biotechnology Sector | ArticleBiz.com
Read more

Global Health Progress Highlights Growth of Brazil's ...

Medicine :: Global Health Progress Highlights Growth of Brazil?s Biotechnology Sector | ArticleBiz.com
Read more

Fact Sheet Reveals Mexico’s Increasing Investment in ...

Global Health Progress highlights ... fact sheet highlights how Mexico’s investment in its biopharmaceutical sector has spurred economic growth, ...
Read more

BIOTECHNOLOGY UPDATE - OECD

GLOBAL FORUM ON BIOTECHNOLOGY 6 ... to evaluate this progress and highlight where ... associated with green growth in the agricultural sector.
Read more

www.newtechnologyinfo.com

www.newtechnologyinfo.com
Read more

Brazil Overview - World Bank

Brazil's economic and social progress between 2003 and 2014 ... global environment and ... World Bank and its branch in the private sector, ...
Read more

cheerfulnu956's social stories · Storify

cheerfulnu956 cheerfulnu956. 50 stories. 0 followers. 1 following. https://storify.com/cheerfulnu956 Follow. Published Delete. Edit. cheerfulnu956 ...
Read more